Tompkins Financial Corp Purchases 1,250 Shares of Aflac Incorporated (NYSE:AFL)

Tompkins Financial Corp increased its holdings in Aflac Incorporated (NYSE:AFLFree Report) by 45.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,019 shares of the financial services provider’s stock after purchasing an additional 1,250 shares during the quarter. Tompkins Financial Corp’s holdings in Aflac were worth $281,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Johnson Financial Group Inc. purchased a new position in shares of Aflac during the fourth quarter valued at approximately $25,000. Silicon Valley Capital Partners purchased a new position in Aflac during the 4th quarter valued at $25,000. CoreFirst Bank & Trust bought a new position in Aflac in the 4th quarter worth $25,000. Guardian Wealth Advisors LLC purchased a new stake in shares of Aflac in the 1st quarter worth about $26,000. Finally, Studio Investment Management LLC bought a new stake in shares of Aflac during the 4th quarter valued at about $27,000. 66.75% of the stock is owned by institutional investors.

Insider Activity at Aflac

In other Aflac news, Director Charles D. Lake II sold 16,040 shares of the company’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $75.86, for a total transaction of $1,216,794.40. Following the transaction, the director now owns 53,925 shares in the company, valued at approximately $4,090,750.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Joseph L. Moskowitz sold 500 shares of Aflac stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $69.60, for a total value of $34,800.00. Following the completion of the sale, the director now owns 27,085 shares of the company’s stock, valued at $1,885,116. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Charles D. Lake II sold 16,040 shares of the stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $75.86, for a total value of $1,216,794.40. Following the completion of the transaction, the director now directly owns 53,925 shares in the company, valued at approximately $4,090,750.50. The disclosure for this sale can be found here. Insiders have sold 30,170 shares of company stock valued at $2,286,000 over the last ninety days. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on AFL shares. Bank of America increased their price target on shares of Aflac from $79.00 to $86.00 in a research note on Wednesday, August 2nd. Jefferies Financial Group lifted their price target on Aflac from $70.00 to $74.00 and gave the company a “hold” rating in a research report on Thursday, September 14th. 58.com reiterated a “reiterates” rating on shares of Aflac in a report on Friday, June 9th. Morgan Stanley cut shares of Aflac from an “overweight” rating to an “equal weight” rating and boosted their target price for the company from $74.00 to $75.00 in a report on Friday, August 18th. Finally, StockNews.com started coverage on shares of Aflac in a research note on Thursday, August 17th. They issued a “hold” rating for the company. Eight analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $75.82.

Get Our Latest Analysis on Aflac

Aflac Stock Up 0.1 %

Aflac stock traded up $0.10 during trading hours on Tuesday, hitting $77.02. The stock had a trading volume of 317,656 shares, compared to its average volume of 2,430,732. The stock’s 50-day moving average price is $74.06 and its 200-day moving average price is $69.11. The stock has a market capitalization of $45.75 billion, a P/E ratio of 10.30, a price-to-earnings-growth ratio of 2.33 and a beta of 0.93. Aflac Incorporated has a 12-month low of $56.03 and a 12-month high of $78.43. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.35.

Aflac (NYSE:AFLGet Free Report) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.16. Aflac had a net margin of 24.48% and a return on equity of 16.10%. The company had revenue of $5.17 billion during the quarter, compared to analyst estimates of $4.52 billion. Equities research analysts anticipate that Aflac Incorporated will post 5.98 EPS for the current fiscal year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 1st. Stockholders of record on Wednesday, August 23rd were issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date was Tuesday, August 22nd. Aflac’s payout ratio is currently 22.46%.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

See Also

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.